<i>MBD4</i> deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients: A retrospective study.

Mathilde Saint‐Ghislain, Manuel Rodrigues, Nathalie Cassoux et al.|Journal of Clinical Oncology|2022

Cited by 2